User: Guest

APHERESIS EQUIPMENT

Global Market Trajectory & Analytics

MCP-1237

VALIDATED EXECUTIVE ENGAGEMENTS

Number of executives repeatedly engaged by snail & email outreach*

POOL + OUTREACH

618

Interactions with Platform & by Email *

INTERACTIONS

124

Unique # Participated *

PARTICIPANTS

23

Responses Validated *

VALIDATIONS

12

* Login to view program details and full enterprise executive list.


  •  DATE

    JULY 2020

  •  TABLES

    405

  •  PAGES

    604

  •  EDITION

    18

  •  PRICE

    USD $5600


GLOBAL EXECUTIVE SURVEY

Impact of Pandemic & Economic Slowdown

Monitor Market Dynamics!
Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.

The global Apheresis Equipment market is projected to reach US$3.1 billion by 2025, driven by the growth in global blood demand as well as supply against a backdrop of aging population and rising prevalence of diseases requiring blood transfusion. The life-saving importance of blood can be put into perspective by the fact that it is the only biological product of ubiquitous importance in surgical theaters and ICUs. Global demand for blood continues to increase, the magnitude of which can be best illustrated by the fact that cancer treatment needs 8 units of blood per patient per procedure, coronary artery bypass surgery requires 5 units of blood, while organ transplants need 10 units of blood. With 18 million new cancer cases diagnosed worldwide every year, with North America alone expected to witness over 470,000 cardiovascular surgeries by 2021 and global CVD mortality rising to 17 million each year and with over 100,000 solid organ transplants are performed each year worldwide, the importance of global need for safe blood cannot be undermined. The rising demand for plasma, platelets and other blood components is throwing the focus on equipment designed for selective isolation of blood components. The scenario provides a fertile environment for the growth of blood collection and processing equipment. Growing concerns over contaminated blood with HIV & Hepatitis is driving investment resources into the development of automated apheresis equipment which requires minimal human contact and intervention.

Other major factors driving growth in the market include increase in voluntary blood donation supported by strong promotional campaigns undertaken by various collection agencies for encouraging blood donation; demand for plasma from biopharmaceutical companies for use in plasma fractionation; new establishment of community blood centers and increased investments in blood and blood component collection equipment; and growing use of apheresis in the treatment of cancer and autoimmune disorders. Growing mainstream practice therapeutic plasma exchange as a result of expanding application of extracorporeal technology is driving the popularity of therapeutic apheresis. The United States represents the largest market worldwide supported by high patient awareness, well-established healthcare infrastructure, supportive reimbursement policies and availability of advanced blood collection technologies. Asia-Pacific including China is a major market led by factors such as rising incidence of disease and sickness among the growing population, government focus on healthcare infrastructure development, easy access to affordable healthcare, increasing number of government licensed and accredited blood banks, launch of numerous new voluntary blood donation camps and higher healthcare spends among the growing base of affluent middle class population.
» Type (Disposable Apheresis Kits, Plasma & Component Separator, Other Types) » Technology (Centrifugation, Membrane Filtration) » Procedure (Plasmapheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, Other Procedures) » Application (Neurology, Hematology, Renal Diseases, Other Applications)
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

  • A: 
    ACTIVE CLIENT
  • B: 
    INACTIVE CLIENT
  • C: 
    ACTIVE PANELIST
  • D: 
    INACTIVE PANELIST
  • E: 
    OPT-INS
  
REPORT INDEX PROJECT COMPENDIUM * EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com